Gene · 2548
Papers2,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's disease. | NPJ Parkinsons Dis | 2023 | 37422510 | PubTator, text mining | PubMed |
| Meeting Abstracts from the 77th Congress of the Italian Society of Pediatrics. | Ital J Pediatr | 2023 | 37420288 | PubTator, text mining | PubMed |
| Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation. | Nat Commun | 2023 | 37400440 | PubTator, text mining | PubMed |
| A novel compound heterozygous variant in ALPK3 induced hypertrophic cardiomyopathy: a case report. | Front Cardiovasc Med | 2023 | 37396576 | PubTator, text mining | PubMed |
| Identification of hypoxia-related genes and exploration of their relationship with immune cells in ischemic stroke. | Sci Rep | 2023 | 37386280 | PubTator, text mining | PubMed |
| Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario. | Biomedicines | 2023 | 37371615 | PubTator, text mining | PubMed |
| Dysregulation of Metabolism and Proteostasis in Skeletal Muscle of a Presymptomatic Pompe Mouse Model. | Cells | 2023 | 37371072 | PubTator, text mining | PubMed |
| Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. | J Exp Clin Cancer Res | 2023 | 37370109 | PubTator, text mining | PubMed |
| Genome-wide association study identifies novel susceptibilities to adult moyamoya disease. | J Hum Genet | 2023 | 37365321 | PubTator, text mining | PubMed |
| Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States. | Front Pharmacol | 2023 | 37361213 | PubTator, text mining | PubMed |
| Progress and Perspective of CRISPR-Cas9 Technology in Translational Medicine. | Adv Sci (Weinh) | 2023 | 37356052 | PubTator, text mining | PubMed |
| Development of high sustained anti-drug antibody titers and corresponding clinical decline in a late-onset Pompe disease patient after 11+ years on enzyme replacement therapy. | Mol Genet Metab Rep | 2023 | 37342670 | PubTator, text mining | PubMed |
| Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet's disease by leveraging gene microarray data. | Immunol Res | 2023 | 37341899 | PubTator, text mining | PubMed |
| Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease. | Neurology | 2023 | 37336766 | PubTator, text mining | PubMed |
| Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia. | Ann Clin Transl Neurol | 2023 | 37334854 | PubTator, text mining | PubMed |
| Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions. | BioDrugs | 2023 | 37326923 | PubTator, text mining | PubMed |
| Reversible Cardiomyopathy, What Should the Clinicians Keep in Mind? A Case Report. | J Saudi Heart Assoc | 2023 | 37325369 | PubTator, text mining | PubMed |
| Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27B. | Sci Rep | 2023 | 37322040 | PubTator, text mining | PubMed |
| Design and Pharmacological Chaperone Effects of N-(4'-Phenylbutyl)-DAB Derivatives Targeting the Lipophilic Pocket of Lysosomal Acid α-Glucosidase. | J Med Chem | 2023 | 37314161 | PubTator, text mining | PubMed |
| Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease. | Mol Genet Genomic Med | 2023 | 37288668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2548/papers?page=16